lyn kinase inhibitors (Cancer Research Technology)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namelyn kinase inhibitors (Cancer Research Technology)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTyrosine-protein kinase Lyn inhibitors
TargetsTyrosine-protein kinase Lyn
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCancer Research Technology
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A